These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7342290

  • 1. Pharmacokinetics of vancomycin in anuria.
    Cunha BA, Quintiliani R, Deglin JM, Izard MW, Nightingale CH.
    Rev Infect Dis; 1981; 3 suppl():S269-72. PubMed ID: 7342290
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
    Moellering RC, Krogstad DJ, Greenblatt DJ.
    Rev Infect Dis; 1981 Jul; 3 suppl():S230-5. PubMed ID: 7342286
    [Abstract] [Full Text] [Related]

  • 4. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML, Cole E, Wolfsdorf J.
    J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G, Acuna V, Perez C, Labarca J, Guevara A, Tagle R.
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacologic clinical monitoring of serum vancomycin levels in pediatric patients].
    Nandí-Lozano E, Ramírez-López E, Avila-Figueroa C.
    Rev Invest Clin; 2003 Feb; 55(3):276-80. PubMed ID: 14515672
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
    Glew RH, Pavuk RA, Shuster A, Alfred HJ.
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
    Ayus JC, Eneas JF, Tong TG, Benowitz NL, Schoenfeld PY, Hadley KL, Becker CE, Humphreys MH.
    Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
    Zimmermann AE, Katona BG, Plaisance KI.
    Pharmacotherapy; 1995 Mar; 15(1):85-91. PubMed ID: 7739950
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H, Francioli P, Ruddy M, Murray HW.
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vancomycin pharmacokinetics in premature infants.
    Gross JR, Kaplan SL, Kramer WG, Mason EO.
    Pediatr Pharmacol (New York); 1985 Jan; 5(1):17-22. PubMed ID: 3991250
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.